Louise Carmody

Louise Carmody

Auto-generated profile, based on publicly available information

Louise Carmody

College of Medicine, Nursing and Health Sciences National University of Ireland Galway Galway Ireland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
DBDelia Bogdanet
Delia Bogdanet
AEAoife Egan
Aoife Egan
CRCatriona Reddin
Catriona Reddin
BKBreda Kirwan
Breda Kirwan
LCLouise Carmody
Louise Carmody
FDFidelma Dunne
Fidelma Dunne

3 August 2021 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
OKOratile Kgosidialwa
Oratile Kgosidialwa
DBDelia Bogdanet
Delia Bogdanet
AEAoife Egan
Aoife Egan
POPaula M. O’shea
Paula M. O’shea
CNChristine Newman
Christine Newman
MLMary R. Loeken
Mary R. Loeken
Objective: To develop a core outcome set (COS) for randomised controlled trials (RCTs) evaluating the effectiveness of interventions for the treatment of pregnant women with pregestational diabetes mellitus (PGDM).Design: A consensus developmental study.Setting: International.Population: Two hundred and five stakeholders completed the first round.Methods: The study consisted of three components. (1) A systematic review of the literature to produce a list of outcomes reported in RCTs assessing the effectiveness of interventions for the treatment of pregnant women with PGDM. (2) A three‐round, online eDelphi survey to prioritise these outcomes by international stakeholders (including healthcare professionals, researchers and women with PGDM). (3) A consensus meeting where stakeholders from each group decided on the final COS.Main outcome measures: All outcomes were extracted from the literature.Results: We extracted 131 unique outcomes from 67 records meeting the full inclusion criteria. Of the 205 stakeholders who completed the first round, 174/205 (85%) and 165/174 (95%) completed rounds 2 and 3, respectively. Participants at the subsequent consensus meeting chose 19 outcomes for inclusion into the COS: trimester‐specific haemoglobin A1c, maternal weight gain during pregnancy, severe maternal hypoglycaemia, diabetic ketoacidosis, miscarriage, pregnancy‐induced hypertension, pre‐eclampsia, maternal death, birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, mode of birth, shoulder dystocia, neonatal hypoglycaemia, congenital malformations, stillbirth and neonatal death.Conclusions: This COS will enable better comparison between RCTs to produce robust evidence synthesis, improve trial reporting and optimise research efficiency in studies assessing treatment of pregnant women with PGDM.Tweetable 165 key stakeholders have developed #Treatment #CoreOutcomes in pregnant women with #diabetes existing before pregnancy.